Hiroaki Kobayashi

Hiroaki (Koby) Kobayashi, MD/MBA, currently serves as a Partner, Principal, and Venture Partner at UTEC - The University of Tokyo Edge Capital Partners since August 2019. In addition, Kobayashi holds board member positions at EnteraSense Limited, Red Arrow Therapeutics, 株式会社フロンティア・フィールド, Metcela Inc., and TXP Medical株式会社. Previous experience includes a role as Manager of Business Development at Boston Scientific and Medical Director at JOMDD, Inc., where responsibilities included managing global commercialization of medical devices. Kobayashi's clinical background features significant roles in emergency medicine and critical care at Hitachi General Hospital and The University of Tokyo Hospital, where leadership was exercised in intensive care units and emergency rooms. Academic qualifications include an MBA from the University of Michigan and an M.D. from The University of Tokyo, complemented by a tenure as a visiting scholar at the University of Pennsylvania School of Medicine.